Results 211 to 220 of about 721,295 (295)
Integrative Multiomics for Prognostic Assessment in Pulmonary Arterial Hypertension. [PDF]
Pi H +5 more
europepmc +1 more source
Objective Aneurysm wall enhancement (AWE) may predict aneurysm growth and rupture in the short‐term, but there is a lack of long‐term follow‐up studies. We aimed to determine whether unruptured intracranial aneurysms (UIAs) with AWE have a higher probability of aneurysm instability during long‐term follow‐up compared with those without AWE. Methods For
Laura T. van der Kamp +9 more
wiley +1 more source
TRPC channels contribute to endothelial dysfunction in pulmonary arterial hypertension. [PDF]
Saint-Martin Willer A +13 more
europepmc +1 more source
Objective Immunothrombosis contributes to ischemic stroke pathophysiology through neutrophil extracellular trap (NET) formation, which promotes thrombus stabilization and microvascular dysfunction. DNase1 is the principal endonuclease responsible for NET degradation.
B. Díaz‐Benito +10 more
wiley +1 more source
Global disease burden of pulmonary arterial hypertension: patterns and inequality in 1990-2021, with projections to 2035. [PDF]
Guan A, Dai Z, Lin J, Chen Q, Jiang C.
europepmc +1 more source
Clot Composition Profiling in Large Vessel Occlusion Stroke Via Radiomics
Objective Clot composition may offer insights into the mechanism of ischemic stroke. Radiomics, a noninvasive imaging technique, enables tissue characterization through radiomic features (RFs). We aimed to evaluate clot composition using radiomics on non‐contrast computed tomography (NCCT).
Andres Gudino +23 more
wiley +1 more source
Left Ventricular Dysfunction Induced by Nonsevere Idiopathic Pulmonary Arterial Hypertension
Mario Kašner +6 more
openalex +2 more sources
Case‐Based Immunology: B Cells and Systemic Sclerosis Interstitial Lung Disease
Interstitial lung disease (ILD) is an important complication of systemic sclerosis (SSc), with high mortality and morbidity. Recent clinical studies in SSc‐ILD have led to US Food and Drug Administration–approved therapies in SSc‐ILD. Importantly, evidence from these studies has been extrapolated to guide management of ILDs of other systemic autoimmune
Nina Goldman +2 more
wiley +1 more source

